Co-ligation of the B cell receptor with complement receptor 2 (CR2/CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway

被引：0
|
作者：
Lyubchenko, T
Dal Porto, J
Cambier, J
Holers, M
机构：
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Natl Jewish Med Res Ctr, Dept Immunol, Denver, CO 80206 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A951 / A951
页数：1
相关论文
共 50 条
  • [1] Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway
    Lyubchenko, T
    dal Porto, J
    Cambier, JC
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2005, 174 (06): : 3264 - 3272
  • [2] The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)
    Mongini, PKA
    Vilensky, MA
    Highet, PF
    Inman, JK
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 3782 - 3791
  • [3] B cell activation leads to shedding of complement receptor type II (CR2/CD21)
    Masilamani, M
    Kassahn, D
    Mikkat, S
    Glocker, MO
    Illges, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) : 2391 - 2397
  • [4] Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21)
    Prodinger, WM
    Schwendinger, MG
    Schoch, J
    Köchle, M
    Larcher, C
    Dierich, MP
    JOURNAL OF IMMUNOLOGY, 1998, 161 (09): : 4604 - 4610
  • [5] MODULATION OF SIGNALING VIA THE B-CELL ANTIGEN RECEPTOR BY CD21, THE RECEPTOR FOR C3DG AND EBV
    LUXEMBOURG, AT
    COOPER, NR
    JOURNAL OF IMMUNOLOGY, 1994, 153 (10): : 4448 - 4457
  • [6] Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg
    Guthridge, JM
    Rakstang, JK
    Young, KA
    Hinshelwood, J
    Aslam, M
    Robertson, A
    Gipson, MG
    Sarrias, MR
    Moore, WT
    Meagher, M
    Karp, D
    Lambris, JD
    Perkins, SJ
    Holers, VM
    BIOCHEMISTRY, 2001, 40 (20) : 5931 - 5941
  • [7] Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)
    Hess, MW
    Schwendinger, MG
    Eskelinen, EL
    Pfaller, K
    Pavelka, M
    Dierich, MP
    Prodinger, WM
    BLOOD, 2000, 95 (08) : 2617 - 2623
  • [8] Molecular characterization of complement receptor 2 (CR2/CD21)-mediated B cell activation triggered by a sub-threshold dose of C3dg-conjugated antigen: CR2 ligation can break tolerance to self antigens
    Lyubchenko, TA
    Dal Porto, JM
    Cambier, JC
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 270 - 271
  • [9] Lymphocytes shed a soluble form of human CD21 (the C3dg/EBV receptor, CR2) that binds iC3b and CD23.
    FremeauxBacchi, V
    Bernard, J
    Maillet, F
    Mani, JC
    Fontaine, M
    Bonnefoy, JY
    Kazatchkine, MD
    Fischer, E
    FASEB JOURNAL, 1996, 10 (06): : 2502 - 2502
  • [10] C3 regulates expression of human complement receptor 2 (CR2, CD21) on mouse B cells
    Marchbank, KJ
    Kulik, L
    Birrell, L
    Haluzcszak, C
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 272 - 272
12345